Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Translation of TRO40303 from myocardial infarction models to demonstration of safety and tolerance in a randomized Phase I trial.
J Transl Med. 2014 Feb 7;12:38. doi: 10.1186/1479-5876-12-38.
J Transl Med. 2014.
PMID: 24507657
Free PMC article.
Clinical Trial.
Derivatization of (+/-)-5-[(2-methylphenoxy)methyl]-2-amino-2-oxazoline, an imidazoline binding sites ligand, with (+)-(R)-alpha-methylbenzyl isocyanate for drug monitoring purposes.
Matoga M, Forfar I, Chaimbault C, Guillon J, Péhourcq F, Bosc JJ, Rettori MC, Jarry C.
Matoga M, et al. Among authors: chaimbault c.
J Enzyme Inhib Med Chem. 2002 Dec;17(6):375-9. doi: 10.1080/1475636021000005640.
J Enzyme Inhib Med Chem. 2002.
PMID: 12683672
Item in Clipboard
Physicochemical and crystallographic evidence for polymorphism of the racemic ethyl (2-chloromethyl-2,3-dihydro-5H-oxazolo [3, 2-a]pyrimidin-5-one)-6-carboxylate.
Chaimbault C, Bosc JJ, Leger JM, Negrier P, Capelle F, Jarry C.
Chaimbault C, et al.
J Pharm Sci. 2000 Nov;89(11):1496-504. doi: 10.1002/1520-6017(200011)89:11<1496::aid-jps12>3.0.co;2-7.
J Pharm Sci. 2000.
PMID: 11015694
Item in Clipboard
Cite
Cite